Company News: Sidekick Health shares exciting data from our latest clinical study in NAFLD

As part of our commitment to generating clinical evidence, Sidekick Health carried out a feasibility study of our NAFLD- digital health program. The study, presented at the American Heart Association’s EPI|Lifestyle 2023 conference, showed significant improvements in liver and cardiometabolic health measures for participants who used Sidekick Health for just 12 weeks. This groundbreaking study suggests that Sidekick Health could be a game-changer in improving health outcomes, helping us in our mission to make a real difference in people's lives.